Tender Details

Country: USA
Summary: Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus
UST Ref No: 126452657
Deadline: 17 Sep 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: W81K0225QA107
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
THIS NOTICE OF INTENT IS NOT A REQUEST FOR QUOTES. A DETERMINATION NOT TO COMPETE THE PROPOSED PROCUREMENT BASED UPON RESPONSES TOTHIS NOTICE IS SOLELY WITHIN THE DISCRETION OF THE GOVERNMENT.
Medical Readiness Contracting Office - Pacific hereby provides notice of its intent to award a sole-source, firm fixed price contract under the authority of FAR 13.106-1(b)(1). As a result, the Government intends to award directly to Qiagen, LLC, Germantown, MD, CAGE 01QT0, in accordance with FAR 13.106-1(b)(1). This requirement is expected to be an indefinite delivery indefinite quantity (IDIQ) contract for a 5-year ordering period.
This requirement is for the procurement of QuantiFERON TB Gold-Plus assay reagents for running QuantiFERON TB-Gold Plus for the detection of Mycobacterium Tuberculosis immune responses by enzyme immunoassay (EIA) at Madigan Army Medical Center (MAMC). The government currently utilizes the DiaSorin LIAISON XL analyzer at MAMC to detect latent Mycobacterium tuberculosis infection. QuantiFERON TB Gold-Plus assays are the only FDA-cleared interferon-gamma release assays that can be used on the analyzer at MAMC without the need to purchase and install additional instrumentation for operability that would only result in partial automation. It would also be necessary to obtain additional physical workspace to accommodate the added system, which MAMC does not have. Therefore, only the QuantiFERON-TB Gold Plus reagents can meet the government-s requirement to ensure continuity of operations, maintain required testing capacity, and meet DHA reference laboratory obligations.
The attached salient characteristics detail the requirements of this anticipated contract action. Market Research has demonstrated that the intended awardee is the only business that is able to meet the requirements.
THIS NOTICE OF INTENT IS NOT A REQUEST FOR QUOTES; no solicitation or RFQ will be forthcoming.
Any firm that believes it can provide the...
Documents:

Salient-Characteristics-Qiagen-LIAISON-QuantiFERON.pdf

If you are registered member, kindly login to view full details of this tender notice:

Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus - USA Tender

The DEPT OF DEFENSE | DEPT OF THE ARMY, a Government sector organization in USA, has announced a new tender for Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus. This tender is published on USARFP under UST Ref No: 126452657 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-17.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.